Remote patient monitoring devices market is predicted to reach USD 76.1 billion at a CAGR of 20.50% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Remote patient monitoring devices market”.

The remote patient monitoring devices market is estimated to register a CAGR of 20.50% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global remote patient monitoring devices market— Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Medical, Nihon Kohden Corporation, Koninklijke Philips N.V., Omron Corporation, F. Hoffmann-La Roche Ltd, American Telecare, Welch Ally, OSI Systems, Inc., Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Dräger Medical, Masimo, Vitls, Inc, Abbott, CareValidate, Biotronik, LifeWatch, Cerner Corporation, Honeywell.

Market Highlights

The global remote patient monitoring devices market is accounted to register a CAGR of 20.50% during the forecast period and is estimated to reach USD 76.1 billion by 2032.

The need for remote patient monitoring is rising as more individuals become ill with chronic illnesses like cancer or non-communicable diseases (NCDs).The need for remote monitoring is emphasized by the growing number of patients with chronic problems, which has a favorable impact on market trends for remote patient monitoring systems. Patients are compelled to visit hospitals more frequently due to the high expense of remote patient monitoring systems. This could compel the government to reduce healthcare spending.

Access full report @ https://www.marketresearchfuture.com/reports/remote-patient-monitoring-devices-market-16104

Segment Analysis

The global remote patient monitoring devices market has been segmented based on product, end-use and application.

On the basis of product, the market is segmented into Vital Sign Monitors, Monitors, Monitoring Devices, Monitoring Devices, Systems Monitoring Devices, Function Monitoring Devices, Devices and Monitors. The vital sign monitors segment was attributed to holding the largest market share in 2022 because there is a greater need for vital sign monitors as the number of people with cardiac diseases rises.

Based on end-use, the global remote patient monitoring devices market has been segmented into Hospital-based Patients, Homecare and Ambulatory Patients. The hospital-based patients segment was expected to hold the largest market share in 2022 because hospitals hire plenty of technical experts and provide a wide range of diagnostic tests to meet patients' requests.

Based on application, the global remote patient monitoring devices market has been segmented into Cancer, Diabetes, Sleep Disorder, Weight Management, Fitness Monitoring, Cardiovascular Diseases Bronchitis, Virus, Dehydration, Infections and Hypertension. The diabetes segment was expected to hold the largest market share in 2022 because diabetes has become one of the main causes of mortality.

Regional Analysis

The global remote patient monitoring devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe remote patient monitoring devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The remote patient monitoring devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World remote patient monitoring devices market comprises of Middle East, Africa, and Latin America.

The largest market share for remote patient monitoring devices was maintained by the North American regional sector. North America accounted for the majority of the market. The growth of this market segment was driven by the rise in the prevalence of chronic diseases, the rise in R&D spending, and the need for wireless and portable systems together with advanced reimbursement policies meant to minimize out-of-pocket expenses. The CDC reports that approximately 47% of US individuals have hypertension, while the American Sleep Association estimates that 50 to 70 million adults in the country suffer from sleep disorders.

Moreover, the Europe market has been persistently growing over the forecast period. The demand for remote patient monitoring devices is driven by Technology advancements in healthcare are a hallmark of Europe. Wearable detectors, connected to the internet of channels, and data analytics are examples of advancements in autonomous devices that improve their usefulness and capabilities and draw in patients and healthcare professionals.

Additionally, the general population of Asia Pacific is aging quickly, which has raised the necessity for ongoing monitoring and contributed to an increase in the prevalence of chronic diseases. The management of these illnesses is made possible by remote patient monitoring systems, which propels market expansion. The Asia Pacific region is home to several nations that are making investments in expanding their healthcare infrastructure, including the use of new technologies. This involves encouraging the use of this gadget.

Furthermore, the rest of the world's remote patient monitoring devices market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's rising use of new technologies. Government support, a rise in investor interest, and the viability of the technology in the sector are all contributing factors to the market expansion.

Key Findings of the Study

• The global remote patient monitoring devices market is expected to reach USD 76.1 billion by 2032, at a CAGR of 20.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the increasing the necessity for ongoing monitoring and contributed to an increase in the prevalence of chronic diseases.


• Based on application, the diabetes segment was expected to hold the largest market share in 2022.


• Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Medical, Nihon Kohden Corporation, Koninklijke Philips N.V., Omron Corporation, F. Hoffmann-La Roche Ltd, American Telecare, Welch Ally, OSI Systems, Inc., Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Dräger Medical, Masimo, Vitls, Inc, Abbott, CareValidate, Biotronik, LifeWatch, Cerner Corporation, Honeywell.